These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27875310)

  • 1. Extending Halogen-based Medicinal Chemistry to Proteins: IODO-INSULIN AS A CASE STUDY.
    El Hage K; Pandyarajan V; Phillips NB; Smith BJ; Menting JG; Whittaker J; Lawrence MC; Meuwly M; Weiss MA
    J Biol Chem; 2016 Dec; 291(53):27023-27041. PubMed ID: 27875310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design.
    Pandyarajan V; Smith BJ; Phillips NB; Whittaker L; Cox GP; Wickramasinghe N; Menting JG; Wan ZL; Whittaker J; Ismail-Beigi F; Lawrence MC; Weiss MA
    J Biol Chem; 2014 Dec; 289(50):34709-27. PubMed ID: 25305014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thing of beauty: Structure and function of insulin's "aromatic triplet".
    Weiss MA; Lawrence MC
    Diabetes Obes Metab; 2018 Sep; 20 Suppl 2(Suppl 2):51-63. PubMed ID: 30230175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions.
    Rege NK; Wickramasinghe NP; Tustan AN; Phillips NFB; Yee VC; Ismail-Beigi F; Weiss MA
    J Biol Chem; 2018 Jul; 293(28):10895-10910. PubMed ID: 29880646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural integrity of the B24 site in human insulin is important for hormone functionality.
    Žáková L; Kletvíková E; Veverka V; Lepsík M; Watson CJ; Turkenburg JP; Jirácek J; Brzozowski AM
    J Biol Chem; 2013 Apr; 288(15):10230-40. PubMed ID: 23447530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution 1H-NMR studies of Des-(B26-B30)-insulin; assignment of resonances and properties of aromatic residues.
    Hua QX; Chen YJ; Wang CC; Wang DC; Roberts GC
    Biochim Biophys Acta; 1989 Feb; 994(2):114-20. PubMed ID: 2642711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical optimization of a therapeutic protein by nonstandard mutagenesis: studies of an iodo-insulin derivative.
    Pandyarajan V; Phillips NB; Cox GP; Yang Y; Whittaker J; Ismail-Beigi F; Weiss MA
    J Biol Chem; 2014 Aug; 289(34):23367-81. PubMed ID: 24993826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of TyrB26 to the Function and Stability of Insulin: STRUCTURE-ACTIVITY RELATIONSHIPS AT A CONSERVED HORMONE-RECEPTOR INTERFACE.
    Pandyarajan V; Phillips NB; Rege N; Lawrence MC; Whittaker J; Weiss MA
    J Biol Chem; 2016 Jun; 291(25):12978-90. PubMed ID: 27129279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
    Zoete V; Meuwly M; Karplus M
    J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.
    Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM
    Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG; Tager HS
    Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex.
    Záková L; Kletvíková E; Lepšík M; Collinsová M; Watson CJ; Turkenburg JP; Jiráček J; Brzozowski AM
    Acta Crystallogr D Biol Crystallogr; 2014 Oct; 70(Pt 10):2765-74. PubMed ID: 25286859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF; Nakagawa SH; Tager HS
    Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Water in the Stability of Wild-type and Mutant Insulin Dimers.
    Raghunathan S; El Hage K; Desmond JL; Zhang L; Meuwly M
    J Phys Chem B; 2018 Jul; 122(28):7038-7048. PubMed ID: 29916244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural consequences of the B5 histidine --> tyrosine mutation in human insulin characterized by X-ray crystallography and conformational analysis.
    Tang L; Whittingham JL; Verma CS; Caves LS; Dodson GG
    Biochemistry; 1999 Sep; 38(37):12041-51. PubMed ID: 10508408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH; Tager HS
    J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions.
    Mirmira RG; Nakagawa SH; Tager HS
    J Biol Chem; 1991 Jan; 266(3):1428-36. PubMed ID: 1988428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
    Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA
    Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.